GOUT AND HYPERURICEMIA
Clinical trials for GOUT AND HYPERURICEMIA explained in plain language.
Never miss a new study
Get alerted when new GOUT AND HYPERURICEMIA trials appear
Sign up with your email to follow new studies for GOUT AND HYPERURICEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New gout pill BR2251 enters Mid-Stage trial
Disease control Not yet recruitingThis Phase 2 trial tests BR2251, a new daily tablet, in 160 adults with gout and high uric acid. Participants receive one of three doses of BR2251 or the standard drug febuxostat for 12 weeks. The goal is to see which dose best lowers uric acid levels and reduces gout flare-ups.
Matched conditions: GOUT AND HYPERURICEMIA
Phase: PHASE2 • Sponsor: BioRay Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Simple DNA test could shield gout patients from deadly skin side effects
Prevention Not yet recruitingThis study tests whether a genetic test can prevent rare but severe skin reactions caused by the common gout drug allopurinol. About 228 Vietnamese adults with gout will either get the test before treatment or receive standard care. Those with a high-risk gene will take a differe…
Matched conditions: GOUT AND HYPERURICEMIA
Phase: PHASE4 • Sponsor: Haiphong University of Medicine and Pharmacy • Aim: Prevention
Last updated Jun 27, 2026 09:00 UTC